JYOTHI MANDAVA: Open Payments
NPI 1891809539 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 36 payments from 15 companies in 2025. Trend: 2023 $1,203 · 2024 $875 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Lundbeck LLC | 2 | $51 |
| Alkermes, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $49 |
Products named: REXULTI, INGREZZA, FANAPT, Qelbree, Auvelity, SPRAVATO, AUSTEDO XR, ARISTADA.
Industry payments across MO — which companies pay providers there.
